Krystal Biotech, Inc. KRYS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $7.55B.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s market capitalization?
- Krystal Biotech, Inc. (KRYS) reported market capitalization of $7.55B in Q1 2026.
- How has Krystal Biotech, Inc.'s market capitalization changed year-over-year?
- Krystal Biotech, Inc.'s market capitalization increased by 45.4% year-over-year, from $5.19B to $7.55B.
- What is the long-term trend for Krystal Biotech, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s market capitalization has grown at a 36.8% compound annual growth rate (CAGR), from $1.49B to $7.15B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.